The 52-Week Low Club
Telik (TELK) Biopharma has drug trial halted. Drops to $2.96 from 52-week high of $20.36. Cache (CACH) Women’s clothing store chain has poor same-store sales and lower guidance. Down to $14.14 from $26.32. Spatialight (HDTV) On the list again. May…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Telik (TELK) Biopharma has drug trial halted. Drops to $2.96 from 52-week high of $20.36.
Cache (CACH) Women’s clothing store chain has poor same-store sales and lower guidance. Down to $14.14 from $26.32.
Spatialight (HDTV) On the list again. May be headed to zero. Liquid crystal microdisplay firm still falling after delisting notice and new financing. $.08 from 52-week high of $3.10.
Nektar Therapeutics (NKTR) Firm helped develop the inhalable insulin Exubera with Pfizer Inc. Pfizer indicates sales are poor, Nektar lays off 25% of staff. Down to $10.80 from from 52-week high of $17.47.
China Sunergy (CSUN) Recent IPO in solar energy market falls to $10.71 after trading at $16.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.
